Dogwood Therapeutics, Inc.
Halneuron
chemotherapy-induced pain
Countdown
86days
Phase 2 readout · ~ Sep 30, 2026 estimated
What's at stake
Phase 2 trial results for Halneuron in chemotherapy-induced pain are due ~ Sep 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 12h ago
“final study data projected for release this fall.”